1.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: hcc-001, NCT00493402
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: hcc-002, NCT00501813
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-001, NCT00554905
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: RFA-002, NCT00555334
|
|
6.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-003, NCT00556803
|
|
7.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-004, NCT00557024
|
|
8.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 25 to 75
Sponsor: Other
Protocol IDs: O2006-415, NCT00375661
|
|
9.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SYSUCC-HCC004, NCT00768157
|
|
10.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: KMUH-IRB-960043, NCT00834860
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to79
Sponsor: Other
Protocol IDs: 2007-07-RCT-LCI1, NCT00561522
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: RFA005, NCT00728078
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EHBH-RCT-2008-009, NCT00814242
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EHBH-RCT-2008-002, NCT00820339
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2004-003883-31, ANRS HC06 LIPIOCIS, NCT00116454
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-HE3002, EU-20629, EUDRACT-2005-003318-13, ISRCTN72785446, CRUK-BILCAP, CRUK-BIBF1120, NCT00363584
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: 07-2007-006, NCT00357422
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: 07-2006-010, NCT00357474
|
|
19.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 to 70
Sponsor: Other
Protocol IDs: 10-2006-001, NCT00397540
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ZSH-LCI-FJ-0001, NCT00460681
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: P051062, EUD 2006-005-456-32, NCT00470340
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12414, 2008-001087-36, STORM, NCT00692770
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Above 20 and under 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: IIC-I01, NCT00699816
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: SunYat-senU 5010, NCT00769106
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-158, NCT00902343
|
